Psychopharmacology

, Volume 122, Issue 2, pp 115–121 | Cite as

Bretazenil modulates sleep EEG and nocturnal hormone secretion in normal men

  • J. Guldner
  • L. Trachsel
  • C. Kratschmayr
  • B. Rothe
  • F. Holsboer
  • A. Steiger
Original Investigation

Abstract

Preclinical data suggest that the imidazo-diazepinone derivative bretazenil (Ro 16-6028) has anxiolytic and anticonvulsant properties with only weak sedative effects. We examined the influence of oral administration of 1 mg bretazenil on the sleep EEG and the concomitant nocturnal secretion of cortisol, growth hormone and prolactin in ten healthy young men. After bretazenil we found a significant increase in stage 2 sleep and a significant reduction in stage 3 sleep. REM latency was prolonged. Spectral analysis of sleep-EEG power revealed a decrease in delta and in theta power and an increase in sigma power. We found no significant influence on sleep onset latency or on intermittent wakefulness. Bretazenil prompted a significant decrease in cortisol secretion and a significant increase in prolactin release. It had no major influence on growth hormone secretion.

Key words

Bretazenil Sleep EEG Cortisol Growth hormone Prolactin GABA benzodiazepine receptor EEG power spectra 

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. Apud JA, Cocchi D, Locatelli V, Masotto C, Müller EE, Racagni G (1989) Biochemical and functional aspects on the control of prolactin release by the hypothalamo-pituitary GABA-ergic system. Psychoneuroendocrinology 14:3–17CrossRefPubMedGoogle Scholar
  2. Balkin TJ, O'Donnel VM, Kamimori GH, Redmond DP, Belenky (1989) Administration of triazolam prior to recovery sleep: effects on sleep architecture, subsequent alertness and performance. Psychopharmacol 99:526–531CrossRefPubMedGoogle Scholar
  3. Beary MD, Lacey JM, Bhat AV (1983) The neuroendocrine impact of 3-hydroxy-diazepam in women. Psychopharmacology 79:295CrossRefPubMedGoogle Scholar
  4. Belzung C, Misslin R, Vogel E (1989) Behavioural effects of the benzodiazepine receptor partial agonist RO 16-6028 in mice. Psychopharmacology 97:388–391CrossRefPubMedGoogle Scholar
  5. Blois R, Gaillard JM (1991) The effects of bretazenil on sleep in healthy young adults. Sleep Res 20A:570Google Scholar
  6. Borbély AA, Mattmann P, Loepfe MK, Strauch I, Lehmann D (1985) Effect of benzodiazepine hypnotics on all-night sleep EEG spectra. Hum Neurobiol 4:189–194PubMedGoogle Scholar
  7. Brunner D, Dijk DJ, Munch M, Borbély AA (1991) Effect of zolpidem on sleep and sleep EEG spectra in healthy young men. Psychopharmacology 104:1–5PubMedGoogle Scholar
  8. Charney DS, Breier A, Jathow PI (1986) Behavioral, biochemical and blood pressure response to alprazolam in healthy subjects: interactions with yohimbine. Psychopharmacology 88:133CrossRefPubMedGoogle Scholar
  9. Christensen P, Lolk A, Gram LF, Kragh-Sorensen P (1992) Benzodiazepine-induced sedation and cortisol suppression. Psychopharmacology 106:511–516CrossRefPubMedGoogle Scholar
  10. Copinschi G, Van Onderbergen A, L'Hermite-Balériaux M, Szyper M, Caufriez A, Bosson D, L'Hermite M, Robyn C, Turek FW, Van Cauter E (1990) Effects of the short-acting benzodiazepine triazolam, taken at bedtime, on circadian and sleep-related hormonal profiles in normal men. Sleep 13:232–244PubMedGoogle Scholar
  11. Costa, Silva JA, Aicoli A, Naylor C, Jones da Silva C, Ferreira I (1983) Midazolam and triazolam in out-patients: a doubleblind comparison of hypnotic efficacy. Br J Clin Pharmacol 16:179S-183SPubMedGoogle Scholar
  12. Darragh A, Tormey WP, Dolphin C (1979) The effects of diazepam on sleep, and on the nocturnal release of growth hormone, prolactin, ACTH and cortisol. Br J Clin Pharmacol 8:90–92PubMedGoogle Scholar
  13. Dijk DJ, Beersma DGM, Daan S, Van den Hoofdakker RH (1989) Effects of seganserin, a 5-HT2antagonist, and temazepam on human sleep stages and EEG power spectra. Eur J Pharmacol 171:207–218CrossRefPubMedGoogle Scholar
  14. Dunn AJ, Berridge CW (1990) Physiological and behavioral response to corticotropin-releasing factor administration: is CRF a mediator of anxiety or stress responses? Brain Res Rev 15:71–100CrossRefPubMedGoogle Scholar
  15. Ehlers CL, Reed TK, Henriksen SJ (1986) Effects of corticotropin-releasing factor and growth hormone-releasing factor on sleep and activity in rats. Neuroendocrinology 42:467–474PubMedGoogle Scholar
  16. Facklam M, Schoch P, Haefely WE (1992) Relationship between benzodiazepine receptor occupancy and potentiation of gamma-aminobutyric acid-stimulated chloride flux in vitro of four ligands of differing intrinsic efficacies. J Pharmacol Exp Ther 261:1113–21PubMedGoogle Scholar
  17. Gaillard JM, Blois R (1989) Differential effects of flunitrazepam on human sleep in combination with flumazenil. Sleep 12:120–132PubMedGoogle Scholar
  18. Gevins AS, Stone RK, Ragsdale SD (1988) Differentiating the effects of three benzodiazepines on non-REM sleep EEG spectra. Neuropsychobiology 19:108–115PubMedGoogle Scholar
  19. Giusti P, Guidetti G, Costa E, Guidotti A (1991) The preferential antagonism of pentyleneterazole proconflict responses differentiates a class of anxiolytic benzodiazepines with potential antipanic action. J Pharmacol Exp Ther 257, 1062–1068PubMedGoogle Scholar
  20. Guldner J, Meschenmoser M, Kratschmayr C, Steiger A (1992) Influence of a benzodiazepine agonist and an antagonist on sleep-EEG and the nocturnal prolactin secretion. Clin Neuropharmacology 15 [Suppl. 1, Part B]:29 BGoogle Scholar
  21. Holsboer F, Bardeleben U von, Steiger A (1988) Effects of intravenous corticotropin-releasing hormone upon sleep-related growth hormone surge and sleep EEG in man. Neuroendocrinology 48:32–38PubMedGoogle Scholar
  22. Holsboer F, Spengler D, Heuser I (1992) The role of corticotropin-releasing hormone in the pathogenesis of Cushing's disease, anorexia nervosa, alcoholism, affective disorders and dementia. Prog Brain Res 93:385–417PubMedGoogle Scholar
  23. Kales A, Bixler EO, Soldatos CR, Jacoby JA, Kales JD (1986) Lorazepam: effects on sleep and withdrawal phenomena. Pharmacology 32:121–130PubMedGoogle Scholar
  24. Kalogeras K, Khan I, Calogero A, Galluci WT, Kling MA, Loriaux Chrousos GP, Gold PW (1987) Effects of alprazolam: a potent benzodiazepine antidepressant on hypothalamic-adrenal function. Clin Res 35:376 AGoogle Scholar
  25. Krueger JM, Obál F (1993) Growth hormone-releasing hormone and interleukin-1 in sleep regulation. FASEB J 7:645–652Google Scholar
  26. Lancel M, Crönlein TAM, Müller-Preuss P, Holsboer F (1994) Pregnenolone enhances EEG delta activity during non-rapid eye movement sleep in the rat, in contrast to midazolam. Brain Res 646:85–94CrossRefPubMedGoogle Scholar
  27. Lopez AL, Kathol RG, Noyes R (1990) Reduction in urinary free cortisol during benzodiazepine treatment of panic disorder. Psychoneuroendocrinology 15:23–28CrossRefPubMedGoogle Scholar
  28. McLeod RM (1976) Regulation of prolactin secretion. In: Martini L, Ganong F (eds) Frontiers in neuroendocrinology, vol. 4. Raven Press, New York, p 169Google Scholar
  29. Nicholson AN, Stone BM (1980) Activity of the hyponotics flunitrazepam and triazolam in man. Br J Pharmacol 9:187–194Google Scholar
  30. Nicosia S, Oliva D, Giannattasio G, Spada A (1983) The role of vasoactive intestinal polypeptide (VIP) as a hypothalamic neurohormone. J Endocrinol Invest 6:235–242PubMedGoogle Scholar
  31. Owens MJ, Bisette G, Nemeroff CB (1989) Acute effects of alprazolam and adinazolam on the concentrations of CRF in the rat brain. Synapse 4:196–202CrossRefPubMedGoogle Scholar
  32. Puia G, Ducic I, Vicini S, Costa E (1992) Molecular mechanisms of the partial allosteric modulatory effects of bretazenil at gamma-aminobutyric acid type A receptor. Proc Natl Acad Sci 89:3620–3624PubMedGoogle Scholar
  33. Racagni G, Apud JA, Cocchi D, Locatelli V, Muller EE (1982) GABA-ergic control of anterior pituitary hormone secretion. Life Sci 31:823–838CrossRefPubMedGoogle Scholar
  34. Rechtschaffen A, Kales A (1968) A manual of standardized terminology, techniques and scoring system for sleep stages of human subjects. National Institute of Health Publication 204, US Government Printing Office, Washington DCGoogle Scholar
  35. Rotsztejn H, Dussaillant M, Nobou F, Rosselin G (1981) Rapid glucocorticoid inhibition of vasoactive intestinal peptide-induced cyclic AMP accumulation and prolactin release in rat pituitary cells in culture. Proc Natl Acad Sci USA 78:7584–7588PubMedGoogle Scholar
  36. Sassin JF, Frantz AG, Kapen S, Weitzman ED (1973) The nocturnal rise of human prolactin is dependent on sleep. J Clin Endocrinol Metab 37:436–440PubMedGoogle Scholar
  37. Schittecatte M, Crine A, Wilmotte J, Kupferberg E (1988) The effects of two benzodiazepines with rapid elimination on sleep, subjective feelings and skilled performance. Curr Ther Res 44:397–401Google Scholar
  38. Steiger A, Bardeleben U von, Herth T, Holsboer F (1989) Sleep EEG and nocturnal secretion of cortisol and growth hormone in male patients with endogenous depression before treatment and after recovery. J Affect Disord 16:189–195CrossRefPubMedGoogle Scholar
  39. Steiger A, Guldner J, Hemmeter U, Rothe B, Wiedemann K, Holsboer F (1992) Effects of growth hormone-relasing hormone and somatostatin on sleep-EEG and nocturnal hormone secretion in male controls. Neuroendocrinology 56:566–573PubMedGoogle Scholar
  40. Steiger A, Trachsel L, Guldner J, Hemmeter U, Rothe B, Rupprecht R, Vedder H, Holsboer F (1993) Neurosteroid pregnenolone induces sleep-EEG changes in man compatible with inverse agonistic GABAA-receptor modulation. Brain Res 615:267–274CrossRefPubMedGoogle Scholar
  41. Steiger A, Guldner J, Lauer CJ, Meschenmoser C, Pollmächer T, Holsboer F (1994) Flumazenil exerts intrinsic activity on sleep EEG and nocturnal hormone secretion in normal controls. Psychopharmacology 113:334–338PubMedGoogle Scholar
  42. Trachsel L (1994) Hartley transforms and narrow bessel bandpass filters produce similar power spectra of multiple frequency oscillators and all-night EEG. Sleep 16 [6]:586–594Google Scholar
  43. Trachsel L, Dijk DJ, Brunner D, Kleene C, Borbély AA (1990) Effect of zopiclone and midazolam on sleep and EEG spectra in a phase advanced sleep schedule. Neuropsychopharmacology 3:11–18PubMedGoogle Scholar
  44. Van Cauter E, Desir D, Refetoff S, Spire JP, Noel P, L'Hermite M, Robyn C, Copinschi G (1982) The relationship between episodic variations of plasma prolactin and REM-non-REM cyclicity is an artifact. J Clin Endocrinol Metab 54:70–75PubMedGoogle Scholar
  45. Weitzman ED (1976) Circadian rhythms and episodic hormone secretion in man. Annu Rev Med 27:225–243CrossRefPubMedGoogle Scholar

Copyright information

© Springer-Verlag 1995

Authors and Affiliations

  • J. Guldner
    • 1
  • L. Trachsel
    • 1
  • C. Kratschmayr
    • 1
  • B. Rothe
    • 1
  • F. Holsboer
    • 1
  • A. Steiger
    • 1
  1. 1.Max Planck Institute of PsychiatryClinical Institute, Department of PsychiatryMunichGermany

Personalised recommendations